Literature DB >> 7996195

Long-term delayed vascularization of human neural transplants to the rat brain.

C Geny1, S Naimi-Sadaoui, R Jeny, A M Belkadi, S L Juliano, M Peschanski.   

Abstract

Human neural transplants are being developed to treat Parkinson's disease. Previous characterization of human transplants focused on neuronal development, while little is known of the interaction between the transplant and its environment, among which blood is of prime importance. We evaluated here the formation of blood vessels in human neural xenografts placed into the brain of rats immunosuppressed with cyclosporin A. Using capillary wall markers, we found that human transplants remain virtually nonvascularized for more than 1 month. Angiogenesis takes place very slowly and the density of blood vessels is still quite poor after 3 months, the fine structure of these capillaries, when they form, is apparently normal. Functional studies indicate that the vascular network formed in the transplant allows blood circulation and exhibits a working barrier to macromolecules. Glucose uptake and consumption and cytochrome oxidase activity are almost undetectable up to 3 months after grafting. These results demonstrate that vascularization is much delayed in human xenografts into the rat brain. This delay is likely to be dependent on the maturation of the transplanted tissue. A dedifferentiation of human endothelial cells cotransplanted with neural cells occurs since histochemical and immunocytochemical markers revealing endothelial cells in the human fetus are not present up to 1 month in the transplant. The origin of this phenomenon is a matter of speculation. How neural cells survive and mature in such conditions are issues of prime interest for the future of human neural grafting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996195      PMCID: PMC6576876     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

Review 1.  Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

Authors:  Oliver Cooper; Arnar Astradsson; Penny Hallett; Harold Robertson; Ivar Mendez; Ole Isacson
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

2.  Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain.

Authors:  J S Guillamo; F Lisovoski; C Christov; C Le Guérinel; G L Defer; M Peschanski; T Lefrançois
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

Review 3.  Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease.

Authors:  Alex Tsui; Ole Isacson
Journal:  J Neurol       Date:  2011-05-05       Impact factor: 4.849

4.  Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

Authors:  Ivar Mendez; Rosario Sanchez-Pernaute; Oliver Cooper; Angel Viñuela; Daniela Ferrari; Lars Björklund; Alain Dagher; Ole Isacson
Journal:  Brain       Date:  2005-05-04       Impact factor: 13.501

5.  Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats.

Authors:  Laetitia Aubry; Aurore Bugi; Nathalie Lefort; France Rousseau; Marc Peschanski; Anselme L Perrier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-15       Impact factor: 11.205

6.  Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage.

Authors:  Yechiel Elkabetz; Georgia Panagiotakos; George Al Shamy; Nicholas D Socci; Viviane Tabar; Lorenz Studer
Journal:  Genes Dev       Date:  2008-01-15       Impact factor: 11.361

Review 7.  Postmortem Studies of Fetal Grafts in Parkinson's Disease: What Lessons Have We Learned?

Authors:  Jia-Yi Li; Wen Li
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 8.  Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?

Authors:  Cristina Salado-Manzano; Unai Perpiña; Marco Straccia; Francisco J Molina-Ruiz; Emanuele Cozzi; Anne E Rosser; Josep M Canals
Journal:  Front Cell Neurosci       Date:  2020-08-11       Impact factor: 6.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.